Do molecularly targeted agents in oncology have reduced attrition rates?

Nat Rev Drug Discov. 2009 Jan;8(1):15-6. doi: 10.1038/nrd2758. Epub 2008 Nov 14.
No abstract available

Publication types

  • News

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Clinical Trials as Topic
  • Drug Approval*
  • Drug Design*
  • Humans
  • Neoplasms / therapy*

Substances

  • Antineoplastic Agents